Compound information
- Natural Products
- ZC3174860
- Molecular Formula
- C23H25F3N2O3
- Molecular Weight
- 434.18172732 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-[[3-[[5-(trifluoromethyl)-2-pyridyl]oxy]phenyl]methylene]piperidine-1-carboxylate
- InChI
- InChI=1S/C23H25F3N2O3/c1-22(2,3)31-21(29)28-11-9-16(10-12-28)13-17-5-4-6-19(14-17)30-20-8-7-18(15-27-20)23(24,25)26/h4-8,13-15H,9-12H2,1-3H3
- InChI Key
- QCDWBPDXKWWGSM-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1
- Source
- ZINC000115024123
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 31 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 51.66 Å2 | LogP | 5.239 |
LogS | -5.986 | LogD | 3.921 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.873 | Pgp substrate | 0.062 |
HIA | 0.966 | F20 % | 0.954 |
F30 % | 0.966 | Caco-2 | -4.558 |
MDCK | -4.755 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.191 | PPB | 97.105 |
VD | 3.563 | Fu | 2.175 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.759 | CYP1A2 substrate | 0.531 |
CYP2A6 substrate | 0.546 | CYP2B6 substrate | 0.693 |
CYP2C19 inhibitor | 0.89 | CYP2C19 substrate | 0.819 |
CYP2C8 substrate | 0.543 | CYP2C9 inhibitor | 0.899 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.356 |
CYP2D6 substrate | 0.816 | CYP2E1 substrate | 0.422 |
CYP3A4 inhibitor | 0.307 | CYP3A4 substrate | 0.999 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.088 | CL | 5.631 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.663 | Hepatotoxicity | 0.179 |
Mutagenicity | 0.024 | Rat Oral Acute Toxicity | 0.675 |
FDAMDD | 0.951 | Skin Sensitization | 0.929 |
Carcinogenicity | 0.289 | Eye Corrosion | 0.001 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.933 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.2 | IGC50 | 4.554 |
LC50FM | 5.108 | LC50DM | 6.342 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.34 | NR-AR-LBD | 0.218 |
NR-AhR | 0.217 | NR-Aromatase | 0.513 |
NR-ER | 0.565 | NR-ER-LBD | 0.517 |
NR-PPAR-gamma | 0.315 | SR-ARE | 0.723 |
SR-ATAD5 | 0.263 | SR-HSE | 0.287 |
SR-MMP | 0.318 | SR-p53 | 0.222 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.